z-logo
Premium
Epidemiology and risk factors for nosocomial bloodstream infections in solid organ transplants over a 10‐year period
Author(s) -
Berenger B.M.,
Doucette K.,
Smith S.W.
Publication year - 2016
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12505
Subject(s) - medicine , intensive care medicine , epidemiology , transplantation , organ transplantation , antibiotics , candida albicans , microbiology and biotechnology , biology
Background Bloodstream infections ( BSI s) are a leading cause of morbidity and mortality in solid organ transplantation ( SOT ). We sought to determine the types of nosocomial BSI s and risk factors for them in SOT . Methods Prospectively collected databases of all SOT and nosocomial BSI s occurring at our institution for a 10‐year period were reviewed. Results From 2003–2012, we observed 157 nosocomial BSI episodes in 2257 SOT s, the majority of which were caused by staphylococci and enterococci (67.5%). The most common sources of BSI were central line, organ space, respiratory, and gastrointestinal. Kidney transplant patients had the lowest risk of acquiring a BSI compared with other SOT types. Lung transplant patients were at increased risk of methicillin‐resistant Staphylococcus aureus BSI and heart transplant patients were at increased risk of a Candida albicans BSI , when compared to other organ transplant types. When coagulase‐negative Staphylococcus (Co NS ) or C. albicans was isolated, the central line was most often the source. The implementation of central‐line bundles during the study period correlated temporally with a decreased rate of Co NS BSI . Over the 10‐year period, vancomycin‐resistant enterococci became the most common enterococcal BSI . Donor‐positive cytomegalovirus status was associated with an increased risk of BSI , when compared to donor‐negative patients. Conclusions This study demonstrates the common sources, risk factors, and causative organisms of BSI , which can guide empiric antibiotic choices, and highlights areas where preventative interventions could be targeted to prevent nosocomial BSI in SOT .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom